OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 80 filers reported holding OYSTER PT PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $25,746,593 | +124.1% | 2,304,977 | +12.8% | 0.53% | +98.5% |
| Q3 2022 | $11,489,000 | +28.9% | 2,044,312 | -0.7% | 0.26% | +15.2% |
| Q2 2022 | $8,913,000 | -62.8% | 2,058,504 | 0.0% | 0.23% | -53.6% |
| Q1 2022 | $23,961,000 | -36.3% | 2,058,504 | 0.0% | 0.50% | -9.7% |
| Q4 2021 | $37,588,000 | +70.4% | 2,058,504 | +10.6% | 0.55% | +64.9% |
| Q3 2021 | $22,055,000 | -31.1% | 1,861,209 | 0.0% | 0.33% | -31.1% |
| Q2 2021 | $31,994,000 | -6.0% | 1,861,209 | 0.0% | 0.48% | -9.0% |
| Q1 2021 | $34,023,000 | -6.1% | 1,861,209 | -3.3% | 0.53% | -12.7% |
| Q4 2020 | $36,240,000 | -10.8% | 1,925,594 | +0.1% | 0.61% | -37.8% |
| Q3 2020 | $40,613,000 | -26.3% | 1,923,893 | +0.8% | 0.98% | -36.9% |
| Q2 2020 | $55,142,000 | +62.5% | 1,909,360 | +96.9% | 1.55% | +6.2% |
| Q1 2020 | $33,932,000 | – | 969,478 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |